| Literature DB >> 33746006 |
Zhanjun Wang1, Yang Song1, Xianling Wang1, Xuying Li2, Fanxi Xu1, Lianghao Si1, Yue Dong1, Tingyan Yao1, Junge Zhu1, Hong Lai1, Wei Li1, Feng Lin3, Huapin Huang3, Chaodong Wang4.
Abstract
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a rare hereditary disease characterized by cerebellar ataxia, pyramidal signs in lower limbs, and sensorimotor neuropathy. The disease is caused by bi-allelic mutations of the SACS gene encoding the sacsin protein. Over 200 mutations have been reported worldwide. Here, we report two unrelated Chinese ARSACS patients with novel mutations revealed by whole-exome sequencing (WES). One 36-year-old female patient exhibited classical ARSACS characteristics including cerebellar ataxia, pyramidal tract signs in the lower limbs and sensorimotor neuropathy, while the other 9-year-old male showed cerebellar ataxia and peripheral neuropathy. WES identified a compound heterozygous variant in the SACS gene (c.5692 G > T, p.E1898X; c.12673-12677 del TATCA, p.Y4225D fs*6) in the female patient and another compound heterozygous variant (c.1773C > A, p.S578X; c.8088-8089 in. CA, p.M2697Q fs*43) in the male patient. All of these novel mutations were predicted to be loss-of-function which affect the expression of the two important C-terminal domains (DnaJ and HEPN). These findings add new insights into the mutational and clinical spectrum of ARSACS.Entities:
Keywords: Autosomal recessive spastic ataxia of Charlevoix-Saguenay; Novel mutations; SACS gene; Whole-exome sequencing
Year: 2021 PMID: 33746006 DOI: 10.1016/j.neulet.2021.135831
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046